Analysis: Baxter International Inc.

US:BAX

Why is Baxter International Inc. stock rising?

  • FY2026 organic sales guidance raised to 2%-3% following stronger first-half performance.
  • PeerVue digital benchmarking application launched for hospitals, adding a digital capability to the IQX infusion platform.
  • Dynamo smart stretcher launched in Canada, marking first international expansion of the product.
  • Vest APX Acute Care airway-clearance device full market release planned toward end of Q3 2026.
  • HST second-half 2026 growth expected to be supported by new product launches including Connex 360 and Dynamo.

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Baxter International Inc. and 4,900+ companies.

Sign in
5-day free pass. No card required.